Document ID: chunk:federal_register_of_legislation:F2020L01083:reg:9
Version: federal_register_of_legislation:F2020L01083
Segment Type: reg
Provision Reference: reg 9
Character Range: 3848–6315

9               Factors that must exist
At least one of the following factors must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting pure red cell aplasia or death from pure red cell aplasia with the circumstances of a person's relevant service:
(1)          being pregnant at the time of the clinical onset of pure red cell aplasia;
(2)          being treated with a drug specified in the Schedule 2 - Drugs of this Instrument within the one year before the clinical onset of pure red cell aplasia;
(3)          being treated with a drug which is associated in the individual with:
(a)          the development of pure red cell aplasia within six months of drug therapy; and
(b)          the improvement of pure red cell aplasia within six months of discontinuing or tapering drug therapy;
(4)          taking a non-aspirin, nonsteroidal, anti-inflammatory drug on at least four days per week for a continuous period of at least four weeks, within the one year before the clinical onset of pure red cell aplasia;
(5)          being exposed to benzene as specified on at least 30 days within the one year before the clinical onset of pure red cell aplasia;
Note: being exposed to benzene as specified is defined in the Schedule 1 - Dictionary.
(6)          having acute hepatitis within the one year before the clinical onset of pure red cell aplasia;
(7)          having a liver transplant within the six months before the clinical onset of pure red cell aplasia;
(8)          having an autoimmune disease from the specified list of autoimmune disease within the two years before the clinical onset of pure red cell aplasia;
Note: specified list of autoimmune diseases is defined in the Schedule 1 - Dictionary.
(9)          having a haematological malignancy from the specified list of haematological malignancies within the six months before the clinical onset of pure red cell aplasia;
Note: specified list of haematological malignancies is defined in the Schedule 1 - Dictionary.
(10)      having a thymoma or thymic carcinoma before the clinical onset of pure red cell aplasia;
(11)      having an infection with parvovirus B19 or acute infectious mononucleosis within the six months before the clinical onset of pure red cell aplasia;
(12)      being pregnant at the time of the clinical worsening of pure red cell aplasia;
(13)      inability to obtain appropriate clinical management for pure red cell aplasia.